| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | Daunorubicin hydrochloride |
|---|
| Description | Anticancer agent that is clinically used to treat nonlymphocytic leukemia. Inhibits RNA and DNA synthesis and causes DNA fragmentation in vivo. Reduces tau mRNA levels in vitro. Purity 98%. MW (observed): 563.99 |
|---|
| Size | 10 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | (8S,10S)-8-Acetyl-10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyransoyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione hydrochloride. Daunomycin |
|---|
| Gene, Accession, CAS # | CAS: 23541-50-6 |
|---|
| Catalog # | 1467/10 |
|---|
| Price | |
|---|
| Order / More Info | Daunorubicin hydrochloride from TOCRIS BIOSCIENCE
|
|---|
| Product Specific References | PubMed: 23322571, 23708834, 28300219 |
|---|
| 產(chǎn)品資料 |
|
|